Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0000950170-25-112043

Options or other derivatives

  • PRESIDENT acquired 3,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sullivan Eddie Joe PRESIDENT 2025-08-26 Grant or award · Stock Option (right to buy) +3,000,000 3,000,000 D
Loading xslF345X05/ownership.xml…